DJSG
QTTB icon

D.J. St. Germain’s Q32 Bio QTTB Stock Holding History

D.J. St. Germain’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11
Closed -$22 – 971
2025
Q3 		$22 Hold
11
– – ﹤0.01% 891
2025
Q2 		$16 Hold
11
– – ﹤0.01% 874
2025
Q1 		$18 Hold
11
– – ﹤0.01% 796
2024
Q4 		$38 Hold
11
– – ﹤0.01% 819
2024
Q3 		$491 Hold
11
– – ﹤0.01% 730
2024
Q2 		$197 Hold
11
– – ﹤0.01% 745
2024
Q1 		$187 Hold
11
– – ﹤0.01% 756
2023
Q4 		$122 Hold
11
– – ﹤0.01% 761
2023
Q3 		$234 Hold
11
– – ﹤0.01% 729
2023
Q2 		$177 Buy
+11
New +$197 ﹤0.01% 704

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.J. St. Germain's QTTB Position: Q4 2025 in Review

D.J. St. Germain sold out of Q32 Bio (QTTB) in Q4 2025, closing a stake of 11 shares — an estimated $22 sold.

D.J. St. Germain first reported a position in QTTB in Q2 2023 and held it in 10 quarters. The position peaked at $491 in Q3 2024. 52 funds tracked by Wall St. Rank hold QTTB as of Q4 2025.

  • D.J. St. Germain reported no remaining Q32 Bio position as of Q4 2025 after selling out during the quarter.
  • D.J. St. Germain sold 11 Q32 Bio shares in Q4 2025, an estimated $22.
  • D.J. St. Germain first reported a position in Q32 Bio in Q2 2023 and held it in 10 quarters.
  • D.J. St. Germain's Q32 Bio position peaked at $491 in Q3 2024.
  • 52 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2025.

Based on D.J. St. Germain's 13F filing for Q4 2025, filed 29 Jan 2026.